美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Inhibrx Biosciences

95.01

+2.252.43%

盤後：95.010.00000.00%19:30 EDT

成交量：8.68萬

成交額：822.67萬

市值：13.94億

市盈率：-10.70

高：95.81

開：92.70

低：92.70

收：92.76

52周最高：155.29

52周最低：28.16

股本：1,467.12萬

流通股本：858.89萬

量比：0.43

換手率：1.01%

股息：- -

股息率：- -

每股收益(TTM):-8.8768

每股收益(LYR):-9.0434

淨資產收益率：-1773.60%

總資產收益率：-43.61%

市淨率：-26.31

市盈率(LYR):-10.51

資料載入中...

總覽公司新聞資訊公告

Inhibrx Biosciences公布實驗性聯合抗癌藥中期研究數據後，股價重挫22%

Inhibrx的聯合抗癌藥物在頭頸部癌症中期臨床試驗中縮小了腫瘤

Inhibrx Biosciences：INBRX-106圍手術期非小細胞肺癌Ⅰ/Ⅱ期臨床試驗進行中，初步結果預計2027年年中公布

Inhibrx Biosciences：擬探索Inbrx-106與治療性癌症疫苗聯合應用的潛力

Inhibrx Biosciences旗下INBRX-106在II期頭頸鱗癌研究中：緩解率近乎翻倍，無進展生存期中位數達9.6個月

H.c. Wainwright首次覆蓋Inhibrx Biosciences，給予買入評級及245美元目標價

Inhibrx因季度虧損幅度超出預期而股價下跌

Inhibrx Biosciences二次修訂協議帶來總計3.25億美元資金，含1億美元已到位與2.25億美元可用額度

Inhibrx宣佈與牛津金融修訂貸款協議，總授信額度增至5億美元

Inhibrx宣佈美國FDA受理Ozekibart用於治療常規軟骨肉瘤患者的生物製品許可申請

Inhibrx Biosciences公司：Inbrx-106聯合帕博利珠單抗觀察到三例完全影像學緩解

Inhibrx Biosciences公司：Inbrx-106聯合帕博利珠單抗確認客觀緩解率達44.0%，顯著優於單藥21.4%

Inhibrx Biosciences公司：Inbrx-106聯合帕博利珠單抗或使系統性T細胞擴增提升高達15倍

Inhibrx公布INBRX-106一線治療HNSCC的2期中期數據；初步結果顯示其較PD-1單藥療法具有潛在共刺激優勢

Inhibrx 將舉辦網絡直播提供一線HNSCC中Inbrx-106六邊形研究臨床進展更新

BUZZ-Inhibrx股價上漲，其與默克Keytruda相關的實驗藥引製藥商關注

Inhibrx Biosciences盤前大漲6.2% 路透報道其實驗性抗癌藥物引默克及同業競逐

獨家-消息人士稱，默克與競爭對手有意就與 Keytruda 相關的 Inhibrx 實驗性抗癌藥物達成交易

Inhibrx將舉辦網絡直播會議公布Ozekibart (INBRX-109)治療晚期結直腸癌臨床進展

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/INBX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INBX\",,,,,undefined,":{"symbol":"INBX","market":"US","secType":"STK","nameCN":"Inhibrx Biosciences","latestPrice":95.01,"timestamp":1791576000000,"preClose":92.76,"halted":0,"volume":86819,"hourTrading":{"tag":"盘后","latestPrice":95.01,"preClose":95.01,"latestTime":"19:30 EDT","volume":8,"amount":761.1,"timestamp":1791588605610,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.024256144890038807,"floatShares":8588900,"shares":14671186,"eps":-8.876818,"marketStatus":"休市中","change":2.25,"latestTime":"10-09 16:00:00 EDT","open":92.7,"high":95.81,"low":92.7,"amount":8226703.64205,"amplitude":0.033527,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.876818,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":92.76,"preHourTrading":{"tag":"盘前","latestPrice":92.41,"preClose":92.76,"latestTime":"08:37 EDT","volume":18,"amount":1683.15012,"timestamp":1791549463616,"change":-0.35,"changeRate":-0.003773,"amplitude":0.020375},"postHourTrading":{"tag":"盘后","latestPrice":95.01,"preClose":95.01,"latestTime":"19:30 EDT","volume":8,"amount":761.1,"timestamp":1791588605610,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4298796004445945,"impliedVol":1.0036,"impliedVolPercentile":0.4821},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INBX\",,,,,undefined,":{"symbol":"INBX","floatShares":8588900,"roa":"-43.61%","roe":"-1773.60%","lyrEps":-9.043391,"volumeRatio":0.4298796004445945,"shares":14671186,"dividePrice":0,"high":95.81,"amplitude":0.033527,"preClose":92.76,"low":92.7,"week52Low":28.16,"pbRate":"-26.31","week52High":155.29,"institutionHeld":0,"latestPrice":95.01,"eps":-8.876818,"divideRate":0,"volume":86819,"delay":0,"ttmEps":-8.876818,"open":92.7,"prevYearClose":79,"prevWeekClose":96.99,"prevMonthClose":100.08,"prevQuarterClose":100.08,"fiveDayClose":96.99,"twentyDayClose":109.27,"sixtyDayClose":89.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INBX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"INBX","fiscalQuarterEnding":"2026/06","expectedEps":-2.5,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-2.34},{"market":"US","date":"2026-05-14","symbol":"INBX","fiscalQuarterEnding":"2026/03","expectedEps":-2.37,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-2.15},{"market":"US","date":"2026-03-19","symbol":"INBX","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":-2.11},{"market":"US","date":"2025-11-14","symbol":"INBX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-2.28},{"market":"US","date":"2025-08-13","symbol":"INBX","fiscalQuarterEnding":"2025/06","expectedEps":-2.92,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-1.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INBX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1787630400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INBX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INBX","date":"2026-10-09","current":-10.70316,"percent":0.218776,"low":-22.314917,"twenty":-10.199014,"median":-6.78817,"eighty":0.095215,"high":0.20643,"avg":-6.595175,"sd":5.006481,"marketCap":1365210141},"quantilePoints":[{"date":"2021-10-15","current":-19.255223,"twenty":-16.545624,"median":-12.97097,"eighty":-9.054369,"marketCap":1504699420},{"date":"2021-10-22","current":-18.493936,"twenty":-16.728002,"median":-13.052038,"eighty":-9.0546,"marketCap":1445208660},{"date":"2021-10-29","current":-19.487973,"twenty":-16.918658,"median":-13.192599,"eighty":-9.065511,"marketCap":1522887678},{"date":"2021-11-05","current":-21.694251,"twenty":-17.230296,"median":-13.217847,"eighty":-9.068239,"marketCap":1695297206},{"date":"2021-11-12","current":-20.979364,"twenty":-17.376546,"median":-13.248255,"eighty":-9.084018,"marketCap":1641173724},{"date":"2021-11-19","current":-21.018179,"twenty":-17.627693,"median":-13.306251,"eighty":-9.093008,"marketCap":1644210123},{"date":"2021-11-26","current":-18.59711,"twenty":-17.724892,"median":-13.36308,"eighty":-9.09439,"marketCap":1454814728},{"date":"2021-12-03","current":-17.903297,"twenty":-17.836807,"median":-13.397679,"eighty":-9.099442,"marketCap":1400539094},{"date":"2021-12-10","current":-19.009517,"twenty":-17.922319,"median":-13.461918,"eighty":-9.105715,"marketCap":1487076469},{"date":"2021-12-17","current":-21.411178,"twenty":-18.339089,"median":-13.523752,"eighty":-9.141289,"marketCap":1674953664},{"date":"2021-12-23","current":-21.576141,"twenty":-18.404686,"median":-13.538298,"eighty":-9.19146,"marketCap":1687858360},{"date":"2021-12-31","current":-21.187994,"twenty":-18.643832,"median":-13.635278,"eighty":-9.244088,"marketCap":1657494369},{"date":"2022-01-07","current":-16.535077,"twenty":-18.65535,"median":-13.71468,"eighty":-9.282247,"marketCap":1293506025},{"date":"2022-01-14","current":-15.273598,"twenty":-18.643832,"median":-13.796526,"eighty":-9.316764,"marketCap":1194823053},{"date":"2022-01-21","current":-13.614268,"twenty":-18.628162,"median":-13.763835,"eighty":-9.324228,"marketCap":1065016991},{"date":"2022-01-28","current":-11.940383,"twenty":-18.576475,"median":-13.688616,"eighty":-9.34366,"marketCap":934072279},{"date":"2022-02-04","current":-12.561419,"twenty":-18.478419,"median":-13.607802,"eighty":-9.350296,"marketCap":982654665},{"date":"2022-02-11","current":-11.285384,"twenty":-18.41052,"median":-13.552845,"eighty":-9.3572,"marketCap":882833044},{"date":"2022-02-18","current":-10.460571,"twenty":-18.383151,"median":-13.530363,"eighty":-9.371993,"marketCap":818309562},{"date":"2022-02-25","current":-10.741978,"twenty":-18.367013,"median":-13.519646,"eighty":-9.383827,"marketCap":840323456},{"date":"2022-03-04","current":-9.688638,"twenty":-18.346841,"median":-13.443599,"eighty":-9.410447,"marketCap":792220573},{"date":"2022-03-11","current":-10.270911,"twenty":-18.333921,"median":-13.396092,"eighty":-9.411627,"marketCap":839831858},{"date":"2022-03-18","current":-12.055911,"twenty":-18.155202,"median":-13.338179,"eighty":-9.438069,"marketCap":985787767},{"date":"2022-03-25","current":-10.30432,"twenty":-18.141037,"median":-13.280794,"eighty":-9.467655,"marketCap":842563653},{"date":"2022-04-01","current":-11.182502,"twenty":-18.091473,"median":-13.235825,"eighty":-9.492956,"marketCap":914370838},{"date":"2022-04-08","current":-10.084775,"twenty":-18.029445,"median":-13.217847,"eighty":-9.550229,"marketCap":824611857},{"date":"2022-04-14","current":-8.743823,"twenty":-17.966571,"median":-13.19269,"eighty":-9.432781,"marketCap":714964912},{"date":"2022-04-22","current":-7.813121,"twenty":-17.912808,"median":-13.077138,"eighty":-9.380868,"marketCap":638863297},{"date":"2022-04-29","current":-7.564934,"twenty":-17.890994,"median":-13.002219,"eighty":-9.337742,"marketCap":618569533},{"date":"2022-05-06","current":-7.426522,"twenty":-17.855642,"median":-12.966698,"eighty":-9.255063,"marketCap":607251857},{"date":"2022-05-13","current":-7.055067,"twenty":-17.833218,"median":-12.861335,"eighty":-9.106701,"marketCap":661292590},{"date":"2022-05-20","current":-5.626562,"twenty":-17.771363,"median":-12.813715,"eighty":-9.084018,"marketCap":527394503},{"date":"2022-05-27","current":-5.684868,"twenty":-17.745237,"median":-12.660732,"eighty":-9.054369,"marketCap":532859731},{"date":"2022-06-03","current":-4.801943,"twenty":-17.737028,"median":-12.627593,"eighty":-8.95124,"marketCap":450100564},{"date":"2022-06-10","current":-4.089773,"twenty":-17.730073,"median":-12.561419,"eighty":-8.884803,"marketCap":383346708},{"date":"2022-06-17","current":-3.781583,"twenty":-17.724892,"median":-12.459267,"eighty":-8.824644,"marketCap":354459074},{"date":"2022-06-24","current":-4.881073,"twenty":-17.720352,"median":-12.408239,"eighty":-8.7684,"marketCap":457517659},{"date":"2022-07-01","current":-4.822767,"twenty":-17.684176,"median":-12.274934,"eighty":-8.715717,"marketCap":452052431},{"date":"2022-07-08","current":-7.17168,"twenty":-17.633745,"median":-12.248836,"eighty":-8.692608,"marketCap":672223046},{"date":"2022-07-15","current":-7.196668,"twenty":-17.617007,"median":-12.144125,"eighty":-8.612608,"marketCap":674565287},{"date":"2022-07-22","current":-8.458584,"twenty":-17.576513,"median":-12.055911,"eighty":-8.581377,"marketCap":792848436},{"date":"2022-07-29","current":-7.221656,"twenty":-17.524355,"median":-11.894179,"eighty":-8.56331,"marketCap":676907527},{"date":"2022-08-05","current":-9.512263,"twenty":-17.400753,"median":-11.861399,"eighty":-8.555407,"marketCap":891612914},{"date":"2022-08-12","current":-8.625805,"twenty":-17.350322,"median":-11.769735,"eighty":-8.539628,"marketCap":955350999},{"date":"2022-08-19","current":-6.788501,"twenty":-17.27656,"median":-11.657921,"eighty":-8.520336,"marketCap":751860455},{"date":"2022-08-26","current":-6.933087,"twenty":-17.270113,"median":-11.575505,"eighty":-8.459312,"marketCap":767874106},{"date":"2022-09-02","current":-5.698815,"twenty":-17.254503,"median":-11.411593,"eighty":-8.433116,"marketCap":631172205},{"date":"2022-09-09","current":-5.543649,"twenty":-17.222227,"median":-11.316139,"eighty":-8.402544,"marketCap":613986823},{"date":"2022-09-16","current":-5.099311,"twenty":-17.176839,"median":-11.219387,"eighty":-8.38282,"marketCap":564774139},{"date":"2022-09-23","current":-5.205105,"twenty":-17.156666,"median":-11.106139,"eighty":-8.343685,"marketCap":576491445},{"date":"2022-09-30","current":-6.330057,"twenty":-16.959985,"median":-11.073112,"eighty":-8.269405,"marketCap":701085463},{"date":"2022-10-07","current":-10.755807,"twenty":-16.908326,"median":-11.043041,"eighty":-8.269405,"marketCap":1191259423},{"date":"2022-10-14","current":-10.526585,"twenty":-16.889381,"median":-10.983634,"eighty":-8.297841,"marketCap":1165871927},{"date":"2022-10-21","current":-10.932132,"twenty":-16.806498,"median":-10.958184,"eighty":-8.303923,"marketCap":1210788266},{"date":"2022-10-28","current":-11.542215,"twenty":-16.768347,"median":-10.953974,"eighty":-8.322526,"marketCap":1278358062},{"date":"2022-11-04","current":-10.914499,"twenty":-16.717916,"median":-10.967397,"eighty":-8.343685,"marketCap":1208835381},{"date":"2022-11-11","current":-11.344191,"twenty":-16.647312,"median":-10.962791,"eighty":-8.354397,"marketCap":1423695985},{"date":"2022-11-18","current":-10.049794,"twenty":-16.62714,"median":-10.967397,"eighty":-8.354465,"marketCap":1261249181},{"date":"2022-11-25","current":-10.525216,"twenty":-16.611581,"median":-10.949764,"eighty":-8.365585,"marketCap":1320914629},{"date":"2022-12-02","current":-11.278257,"twenty":-16.580652,"median":-10.937999,"eighty":-8.379929,"marketCap":1415421215},{"date":"2022-12-09","current":-9.435563,"twenty":-16.54284,"median":-10.900911,"eighty":-8.38732,"marketCap":1184163164},{"date":"2022-12-16","current":-9.373099,"twenty":-16.531101,"median":-10.878658,"eighty":-8.393763,"marketCap":1176323908},{"date":"2022-12-23","current":-8.609648,"twenty":-16.490733,"median":-10.784251,"eighty":-8.401054,"marketCap":1080510779},{"date":"2022-12-30","current":-8.550654,"twenty":-16.480889,"median":-10.755807,"eighty":-8.386195,"marketCap":1073107038},{"date":"2023-01-06","current":-8.026649,"twenty":-16.471483,"median":-10.69346,"eighty":-8.360025,"marketCap":1007344390},{"date":"2023-01-13","current":-8.210571,"twenty":-16.426351,"median":-10.672935,"eighty":-8.338773,"marketCap":1030426644},{"date":"2023-01-20","current":-8.391023,"twenty":-16.377843,"median":-10.653608,"eighty":-8.307919,"marketCap":1053073383},{"date":"2023-01-27","current":-9.418212,"twenty":-16.362213,"median":-10.622351,"eighty":-8.325121,"marketCap":1181985593},{"date":"2023-02-03","current":-8.953201,"twenty":-16.33033,"median":-10.598102,"eighty":-8.337136,"marketCap":1123626687},{"date":"2023-02-10","current":-8.016238,"twenty":-16.291538,"median":-10.582191,"eighty":-8.307919,"marketCap":1006037848},{"date":"2023-02-17","current":-8.311208,"twenty":-16.132459,"median":-10.5517,"eighty":-8.275092,"marketCap":1043056556},{"date":"2023-02-24","current":-8.030119,"twenty":-16.054745,"median":-10.525901,"eighty":-8.231392,"marketCap":1007779905},{"date":"2023-03-03","current":-8.387553,"twenty":-15.986664,"median":-10.497454,"eighty":-8.231392,"marketCap":1052637869},{"date":"2023-03-10","current":-6.435629,"twenty":-15.890044,"median":-10.456763,"eighty":-8.19669,"marketCap":934620687},{"date":"2023-03-17","current":-6.270613,"twenty":-15.797914,"median":-10.414026,"eighty":-8.099523,"marketCap":910656054},{"date":"2023-03-24","current":-5.790566,"twenty":-15.764767,"median":-10.407228,"eighty":-8.067817,"marketCap":840940758},{"date":"2023-03-31","current":-5.661554,"twenty":-15.730029,"median":-10.399775,"eighty":-8.033589,"marketCap":822204772},{"date":"2023-04-06","current":-5.208509,"twenty":-15.644351,"median":-10.35682,"eighty":-8.023608,"marketCap":756410961},{"date":"2023-04-14","current":-5.499418,"twenty":-15.574223,"median":-10.30432,"eighty":-7.994722,"marketCap":798658421},{"date":"2023-04-21","current":-5.892662,"twenty":-15.521886,"median":-10.270911,"eighty":-7.963641,"marketCap":855767729},{"date":"2023-04-28","current":-6.192849,"twenty":-15.371285,"median":-10.226889,"eighty":-7.840005,"marketCap":899362621},{"date":"2023-05-05","current":-8.07802,"twenty":-15.311904,"median":-10.209425,"eighty":-7.808348,"marketCap":1173138543},{"date":"2023-05-12","current":-6.709665,"twenty":-15.280047,"median":-10.16535,"eighty":-7.729148,"marketCap":1092923942},{"date":"2023-05-19","current":-6.50133,"twenty":-15.255016,"median":-10.150431,"eighty":-7.546255,"marketCap":1058988661},{"date":"2023-05-26","current":-6.166624,"twenty":-15.230664,"median":-10.123541,"eighty":-7.399027,"marketCap":1004469064},{"date":"2023-06-02","current":-6.482587,"twenty":-15.150093,"median":-10.101438,"eighty":-7.301546,"marketCap":1055935564},{"date":"2023-06-09","current":-6.578982,"twenty":-15.099664,"median":-10.081052,"eighty":-7.190357,"marketCap":1071637208},{"date":"2023-06-16","current":-7.449218,"twenty":-15.081916,"median":-10.06194,"eighty":-7.181675,"marketCap":1213388161},{"date":"2023-06-23","current":-7.130577,"twenty":-15.043354,"median":-10.049658,"eighty":-7.147018,"marketCap":1161485505},{"date":"2023-06-30","current":-6.889589,"twenty":-14.978471,"median":-10.010787,"eighty":-7.109449,"marketCap":1122231394},{"date":"2023-07-07","current":-6.694121,"twenty":-14.879324,"median":-10.003176,"eighty":-7.080055,"marketCap":1090391950},{"date":"2023-07-14","current":-6.71822,"twenty":-14.813575,"median":-9.929589,"eighty":-7.055067,"marketCap":1094317361},{"date":"2023-07-21","current":-6.734286,"twenty":-14.720843,"median":-9.757019,"eighty":-7.020794,"marketCap":1096934301},{"date":"2023-07-28","current":-5.612351,"twenty":-14.603223,"median":-9.723592,"eighty":-6.959208,"marketCap":914184610},{"date":"2023-08-04","current":-5.398139,"twenty":-14.56955,"median":-9.684017,"eighty":-6.913688,"marketCap":879292068},{"date":"2023-08-11","current":-4.03189,"twenty":-14.558043,"median":-9.636138,"eighty":-6.825667,"marketCap":694323632},{"date":"2023-08-18","current":-4.184036,"twenty":-14.524162,"median":-9.629385,"eighty":-6.795871,"marketCap":720524524},{"date":"2023-08-25","current":-4.754587,"twenty":-14.503242,"median":-9.590932,"eighty":-6.760289,"marketCap":818777868},{"date":"2023-09-01","current":-5.426568,"twenty":-14.469299,"median":-9.50261,"eighty":-6.734286,"marketCap":934498474},{"date":"2023-09-08","current":-5.464605,"twenty":-14.447925,"median":-9.46202,"eighty":-6.706556,"marketCap":941048697},{"date":"2023-09-15","current":-5.071559,"twenty":-14.422502,"median":-9.438069,"eighty":-6.644838,"marketCap":873363060},{"date":"2023-09-22","current":-4.949842,"twenty":-14.389111,"median":-9.414919,"eighty":-6.609239,"marketCap":852402346},{"date":"2023-09-29","current":-4.617655,"twenty":-14.346133,"median":-9.407047,"eighty":-6.577375,"marketCap":795197066},{"date":"2023-10-06","current":-4.749515,"twenty":-14.31098,"median":-9.378463,"eighty":-6.507756,"marketCap":817904505},{"date":"2023-10-13","current":-4.513688,"twenty":-14.290456,"median":-9.369034,"eighty":-6.480396,"marketCap":777293123},{"date":"2023-10-20","current":-4.009068,"twenty":-14.254834,"median":-9.345778,"eighty":-6.435381,"marketCap":690393498},{"date":"2023-10-27","current":-3.867064,"twenty":-14.245721,"median":-9.330985,"eighty":-6.382845,"marketCap":665939333},{"date":"2023-11-03","current":-4.062319,"twenty":-14.23073,"median":-9.300224,"eighty":-6.304458,"marketCap":699563811},{"date":"2023-11-10","current":-4.235537,"twenty":-14.186119,"median":-9.266506,"eighty":-6.270701,"marketCap":799127199},{"date":"2023-11-17","current":-5.26616,"twenty":-14.175985,"median":-9.233113,"eighty":-6.246101,"marketCap":993576892},{"date":"2023-11-24","current":-5.148354,"twenty":-14.166482,"median":-9.221106,"eighty":-6.167838,"marketCap":971350279},{"date":"2023-12-01","current":-5.206004,"twenty":-14.131341,"median":-9.105221,"eighty":-6.111798,"marketCap":982227132},{"date":"2023-12-08","current":-6.356488,"twenty":-14.04259,"median":-9.094269,"eighty":-6.096789,"marketCap":1199291289},{"date":"2023-12-15","current":-6.902905,"twenty":-14.028044,"median":-9.068239,"eighty":-6.096789,"marketCap":1302384941},{"date":"2023-12-22","current":-7.489427,"twenty":-14.025921,"median":-9.0546,"eighty":-6.100835,"marketCap":1413045100},{"date":"2023-12-29","current":-8.757716,"twenty":-14.008907,"median":-9.009394,"eighty":-6.107413,"marketCap":1652335870},{"date":"2024-01-05","current":-9.281575,"twenty":-13.987173,"median":-9.0546,"eighty":-6.120086,"marketCap":1751173361},{"date":"2024-01-12","current":-9.274056,"twenty":-13.943671,"median":-9.061419,"eighty":-6.154509,"marketCap":1749754642},{"date":"2024-01-19","current":-8.211299,"twenty":-13.935913,"median":-9.054023,"eighty":-6.159602,"marketCap":1549242218},{"date":"2024-01-26","current":-9.416751,"twenty":-13.905441,"median":-9.0546,"eighty":-6.166624,"marketCap":1776677287},{"date":"2024-02-02","current":-9.534775,"twenty":-13.893773,"median":-9.068239,"eighty":-6.167838,"marketCap":1798944976},{"date":"2024-02-09","current":-9.356484,"twenty":-13.878644,"median":-9.094269,"eighty":-6.192849,"marketCap":1765306552},{"date":"2024-02-16","current":-9.539797,"twenty":-13.835161,"median":-9.100679,"eighty":-6.225609,"marketCap":1799892537},{"date":"2024-02-23","current":-9.625175,"twenty":-13.830421,"median":-9.105273,"eighty":-6.230052,"marketCap":1816001078},{"date":"2024-03-01","current":-7.192485,"twenty":-13.817912,"median":-9.107687,"eighty":-6.241337,"marketCap":1735985333},{"date":"2024-03-08","current":-7.02362,"twenty":-13.807049,"median":-9.100679,"eighty":-6.252765,"marketCap":1695227829},{"date":"2024-03-15","current":-6.870463,"twenty":-13.801122,"median":-9.094269,"eighty":-6.255798,"marketCap":1658261720},{"date":"2024-03-22","current":-6.866535,"twenty":-13.794357,"median":-9.068239,"eighty":-6.258187,"marketCap":1657313871},{"date":"2024-03-28","current":-6.901879,"twenty":-13.75802,"median":-9.0546,"eighty":-6.261305,"marketCap":1665844512},{"date":"2024-04-05","current":-6.803702,"twenty":-13.722712,"median":-8.965343,"eighty":-6.267575,"marketCap":1642148288},{"date":"2024-04-12","current":-6.876353,"twenty":-13.699042,"median":-8.949082,"eighty":-6.270876,"marketCap":1659683493},{"date":"2024-04-19","current":-6.764431,"twenty":-13.676978,"median":-8.940031,"eighty":-6.285296,"marketCap":1632669799},{"date":"2024-04-26","current":-6.693743,"twenty":-13.636249,"median":-8.888993,"eighty":-6.295007,"marketCap":1615608518},{"date":"2024-05-03","current":-6.678035,"twenty":-13.606508,"median":-8.861134,"eighty":-6.300411,"marketCap":1611817122},{"date":"2024-05-10","current":-6.811556,"twenty":-13.591628,"median":-8.831645,"eighty":-6.305537,"marketCap":1644043986},{"date":"2024-05-17","current":-6.66535,"twenty":-13.56577,"median":-8.821685,"eighty":-6.320681,"marketCap":1807342945},{"date":"2024-05-24","current":-6.607374,"twenty":-13.544117,"median":-8.774994,"eighty":-6.333212,"marketCap":1791622362},{"date":"2024-05-31","current":-6.591913,"twenty":-13.536996,"median":-8.765808,"eighty":-6.33955,"marketCap":1787430207},{"date":"2024-06-07","current":-1.428017,"twenty":-13.534391,"median":-8.762512,"eighty":-6.320681,"marketCap":235088680},{"date":"2024-06-14","current":-1.458793,"twenty":-13.530648,"median":-8.74769,"eighty":-6.294936,"marketCap":240155247},{"date":"2024-06-21","current":-1.274136,"twenty":-13.527902,"median":-8.742788,"eighty":-6.264538,"marketCap":209755848},{"date":"2024-06-28","current":-1.236325,"twenty":-13.525827,"median":-8.73905,"eighty":-6.257641,"marketCap":203531210},{"date":"2024-07-05","current":-1.181807,"twenty":-13.520467,"median":-8.720695,"eighty":-6.23625,"marketCap":194556149},{"date":"2024-07-12","current":-1.1651,"twenty":-13.501419,"median":-8.701753,"eighty":-6.16711,"marketCap":191805728},{"date":"2024-07-15","current":-1.168617,"twenty":-13.494359,"median":-8.700162,"eighty":-6.163815,"marketCap":192384764},{"date":"2024-08-02","current":-1.28117,"twenty":-13.487298,"median":-8.699924,"eighty":-6.158329,"marketCap":210913921},{"date":"2024-08-09","current":-1.005943,"twenty":-13.450927,"median":-8.696095,"eighty":-6.09615,"marketCap":165604341},{"date":"2024-08-16","current":0.104301,"twenty":-13.431551,"median":-8.6648,"eighty":-6.071261,"marketCap":179428830},{"date":"2024-08-23","current":0.109307,"twenty":-13.403851,"median":-8.63741,"eighty":-5.995926,"marketCap":188041992},{"date":"2024-08-30","current":0.117049,"twenty":-13.39514,"median":-8.624442,"eighty":-5.904035,"marketCap":201359824},{"date":"2024-09-06","current":0.134972,"twenty":-13.390591,"median":-8.609648,"eighty":-5.798831,"marketCap":232193500},{"date":"2024-09-13","current":0.126894,"twenty":-13.3581,"median":-8.599787,"eighty":-5.718185,"marketCap":218296632},{"date":"2024-09-20","current":0.147174,"twenty":-13.320535,"median":-8.57594,"eighty":-5.693236,"marketCap":253183560},{"date":"2024-09-27","current":0.128998,"twenty":-13.305746,"median":-8.560338,"eighty":-5.649553,"marketCap":221915608},{"date":"2024-10-04","current":0.125211,"twenty":-13.276207,"median":-8.555407,"eighty":-5.607263,"marketCap":215401451},{"date":"2024-10-11","current":0.131102,"twenty":-13.252097,"median":-8.535683,"eighty":-5.58388,"marketCap":225534584},{"date":"2024-10-18","current":0.136066,"twenty":-13.240797,"median":-8.522393,"eighty":-5.549996,"marketCap":234075367},{"date":"2024-10-25","current":0.129334,"twenty":-13.231179,"median":-8.49513,"eighty":-5.503238,"marketCap":222494644},{"date":"2024-10-31","current":0.137076,"twenty":-13.224048,"median":-8.462226,"eighty":-5.484857,"marketCap":235812476},{"date":"2024-11-08","current":0.136824,"twenty":-13.217877,"median":-8.459506,"eighty":-5.448787,"marketCap":235378199},{"date":"2024-11-15","current":0.12003,"twenty":-13.207731,"median":-8.443665,"eighty":-5.380467,"marketCap":207439704},{"date":"2024-11-22","current":0.117098,"twenty":-13.192708,"median":-8.434596,"eighty":-5.31642,"marketCap":202373137},{"date":"2024-11-29","current":0.12782,"twenty":-13.171515,"median":-8.426987,"eighty":-5.264154,"marketCap":220902295},{"date":"2024-12-06","current":0.12648,"twenty":-13.08517,"median":-8.411844,"eighty":-5.216231,"marketCap":218586150},{"date":"2024-12-13","current":0.123548,"twenty":-13.067098,"median":-8.398818,"eighty":-5.199699,"marketCap":213519584},{"date":"2024-12-20","current":0.116261,"twenty":-13.024078,"median":-8.388445,"eighty":-5.177816,"marketCap":200925547},{"date":"2024-12-27","current":0.12514,"twenty":-13.01264,"median":-8.38282,"eighty":-5.148354,"marketCap":216270005},{"date":"2025-01-03","current":0.127736,"twenty":-12.995966,"median":-8.368365,"eighty":-5.142063,"marketCap":220757536},{"date":"2025-01-10","current":0.125475,"twenty":-12.979301,"median":-8.354397,"eighty":-5.097874,"marketCap":216849041},{"date":"2025-01-17","current":0.113413,"twenty":-12.968407,"median":-8.346533,"eighty":-5.070194,"marketCap":196003740},{"date":"2025-01-24","current":0.109644,"twenty":-12.940438,"median":-8.330294,"eighty":-5.039101,"marketCap":189489583},{"date":"2025-01-31","current":0.113497,"twenty":-12.895226,"median":-8.311208,"eighty":-4.971878,"marketCap":196148499},{"date":"2025-02-07","current":0.108471,"twenty":-12.866366,"median":-8.300882,"eighty":-4.937061,"marketCap":187462956},{"date":"2025-02-14","current":0.110063,"twenty":-12.829543,"median":-8.262624,"eighty":-4.888294,"marketCap":190213378},{"date":"2025-02-21","current":0.107215,"twenty":-12.818415,"median":-8.231392,"eighty":-4.86555,"marketCap":185291571},{"date":"2025-02-28","current":0.105539,"twenty":-12.791099,"median":-8.210935,"eighty":-4.812772,"marketCap":182396390},{"date":"2025-03-07","current":0.11157,"twenty":-12.69316,"median":-8.180554,"eighty":-4.789981,"marketCap":192819041},{"date":"2025-03-14","current":0.118522,"twenty":-12.662245,"median":-8.128541,"eighty":-4.744813,"marketCap":204834041},{"date":"2025-03-21","current":0.120949,"twenty":-12.654648,"median":-8.099523,"eighty":-4.702077,"marketCap":204110246},{"date":"2025-03-28","current":0.122836,"twenty":-12.635275,"median":-8.082172,"eighty":-4.65634,"marketCap":207294945},{"date":"2025-04-04","current":0.114344,"twenty":-12.608867,"median":-8.067817,"eighty":-4.615626,"marketCap":192963800},{"date":"2025-04-11","current":0.097102,"twenty":-12.580425,"median":-8.059594,"eighty":-4.551429,"marketCap":163867233},{"date":"2025-04-17","current":0.098389,"twenty":-12.561419,"median":-8.031854,"eighty":-4.48833,"marketCap":166038618},{"date":"2025-04-25","current":0.102764,"twenty":-12.551715,"median":-8.025451,"eighty":-4.412256,"marketCap":173421329},{"date":"2025-05-02","current":0.10568,"twenty":-12.478937,"median":-8.000315,"eighty":-4.235537,"marketCap":178343137},{"date":"2025-05-09","current":0.096588,"twenty":-12.439597,"median":-7.991946,"eighty":-4.089773,"marketCap":162998679},{"date":"2025-05-16","current":0.100989,"twenty":-12.434577,"median":-7.97539,"eighty":-4.044568,"marketCap":174000366},{"date":"2025-05-23","current":0.105357,"twenty":-12.381901,"median":-7.908838,"eighty":-3.993853,"marketCap":181527836},{"date":"2025-05-30","current":0.115524,"twenty":-12.32239,"median":-7.842802,"eighty":-3.849968,"marketCap":199043680},{"date":"2025-06-06","current":0.108298,"twenty":-12.28145,"median":-7.820969,"eighty":-3.684995,"marketCap":186594402},{"date":"2025-06-13","current":0.120397,"twenty":-12.27012,"median":-7.741529,"eighty":-1.480952,"marketCap":207439704},{"date":"2025-06-20","current":0.12779,"twenty":-12.256868,"median":-7.679625,"eighty":-1.456331,"marketCap":220178499},{"date":"2025-06-27","current":0.124261,"twenty":-12.215704,"median":-7.603614,"eighty":-1.340788,"marketCap":214098620},{"date":"2025-07-03","current":0.1372,"twenty":-12.181568,"median":-7.503213,"eighty":-1.260418,"marketCap":236391512},{"date":"2025-07-11","current":0.176268,"twenty":-12.147999,"median":-7.450386,"eighty":-1.219442,"marketCap":303704465},{"date":"2025-07-18","current":0.198448,"twenty":-12.097216,"median":-7.41608,"eighty":-1.173893,"marketCap":341920852},{"date":"2025-07-25","current":0.193827,"twenty":-12.055911,"median":-7.368888,"eighty":-1.136258,"marketCap":333959105},{"date":"2025-08-01","current":0.184165,"twenty":-12.0097,"median":-7.300695,"eighty":-1.006646,"marketCap":317311815},{"date":"2025-08-08","current":0.179293,"twenty":-11.932996,"median":-7.27517,"eighty":0.093431,"marketCap":308915791},{"date":"2025-08-15","current":-2.118471,"twenty":-11.899726,"median":-7.210926,"eighty":0.095163,"marketCap":346780978},{"date":"2025-08-22","current":-2.137939,"twenty":-11.899726,"median":-7.188912,"eighty":0.095163,"marketCap":349967771},{"date":"2025-08-29","current":-2.467125,"twenty":-11.899726,"median":-7.117001,"eighty":0.095163,"marketCap":403853537},{"date":"2025-09-05","current":-2.452966,"twenty":-11.910821,"median":-7.080055,"eighty":0.095189,"marketCap":401535870},{"date":"2025-09-12","current":-2.517565,"twenty":-11.899726,"median":-7.052928,"eighty":0.095163,"marketCap":412110227},{"date":"2025-09-19","current":-2.358281,"twenty":-11.899726,"median":-7.022207,"eighty":0.095163,"marketCap":386036469},{"date":"2025-09-26","current":-2.817991,"twenty":-11.899726,"median":-6.994363,"eighty":0.095163,"marketCap":461288231},{"date":"2025-10-03","current":-3.102932,"twenty":-11.899726,"median":-6.957161,"eighty":0.095163,"marketCap":507931287},{"date":"2025-10-10","current":-3.09718,"twenty":-11.899726,"median":-6.916619,"eighty":0.095163,"marketCap":506989735},{"date":"2025-10-17","current":-3.238323,"twenty":-11.899726,"median":-6.888862,"eighty":0.095163,"marketCap":530093981},{"date":"2025-10-24","current":-2.5096,"twenty":-11.899726,"median":-6.871444,"eighty":0.095163,"marketCap":410806539},{"date":"2025-10-31","current":-6.947417,"twenty":-11.899726,"median":-6.866535,"eighty":0.095163,"marketCap":1137250402},{"date":"2025-11-07","current":-7.166874,"twenty":-11.899726,"median":-6.866535,"eighty":0.095163,"marketCap":1173174246},{"date":"2025-11-14","current":-6.603187,"twenty":-11.899726,"median":-6.865553,"eighty":0.095163,"marketCap":1080902115},{"date":"2025-11-21","current":-7.487278,"twenty":-11.861937,"median":-6.865553,"eighty":0.095163,"marketCap":1161172041},{"date":"2025-11-28","current":-7.88865,"twenty":-11.742377,"median":-6.865553,"eighty":0.095163,"marketCap":1223419240},{"date":"2025-12-05","current":-8.197182,"twenty":-11.617777,"median":-6.865553,"eighty":0.095163,"marketCap":1271268138},{"date":"2025-12-12","current":-7.709533,"twenty":-11.403957,"median":-6.865553,"eighty":0.095163,"marketCap":1195640700},{"date":"2025-12-19","current":-8.001185,"twenty":-11.337354,"median":-6.865553,"eighty":0.095163,"marketCap":1240871726},{"date":"2025-12-26","current":-7.536043,"twenty":-11.289254,"median":-6.865553,"eighty":0.095163,"marketCap":1168734785},{"date":"2026-01-02","current":-7.408504,"twenty":-11.181733,"median":-6.865553,"eighty":0.095163,"marketCap":1148955302},{"date":"2026-01-09","current":-7.052146,"twenty":-11.074324,"median":-6.865553,"eighty":0.095163,"marketCap":1093689097},{"date":"2026-01-16","current":-6.733299,"twenty":-10.974222,"median":-6.860645,"eighty":0.095163,"marketCap":1044240388},{"date":"2026-01-23","current":-7.454456,"twenty":-10.939172,"median":-6.859408,"eighty":0.095163,"marketCap":1156081733},{"date":"2026-01-30","current":-6.804571,"twenty":-10.880889,"median":-6.848864,"eighty":0.095163,"marketCap":1055293629},{"date":"2026-02-06","current":-7.645764,"twenty":-10.722571,"median":-6.848864,"eighty":0.095163,"marketCap":1185750959},{"date":"2026-02-13","current":-7.700156,"twenty":-10.655341,"median":-6.848864,"eighty":0.095163,"marketCap":1194186327},{"date":"2026-02-20","current":-7.603564,"twenty":-10.601716,"median":-6.848864,"eighty":0.095163,"marketCap":1179206277},{"date":"2026-02-27","current":-7.242516,"twenty":-10.568541,"median":-6.848864,"eighty":0.095163,"marketCap":1123212885},{"date":"2026-03-06","current":-6.626391,"twenty":-10.505783,"median":-6.845284,"eighty":0.095163,"marketCap":1027660527},{"date":"2026-03-13","current":-6.498853,"twenty":-10.428161,"median":-6.829185,"eighty":0.095163,"marketCap":1007881043},{"date":"2026-03-20","current":-6.765617,"twenty":-10.386411,"median":-6.812729,"eighty":0.095163,"marketCap":947558425},{"date":"2026-03-27","current":-6.861568,"twenty":-10.343704,"median":-6.806916,"eighty":0.095163,"marketCap":960996898},{"date":"2026-04-02","current":-6.99298,"twenty":-10.343704,"median":-6.799786,"eighty":0.095163,"marketCap":979401763},{"date":"2026-04-10","current":-7.900346,"twenty":-10.298288,"median":-6.792174,"eighty":0.095163,"marketCap":1106482977},{"date":"2026-04-17","current":-8.667957,"twenty":-10.251785,"median":-6.792174,"eighty":0.095163,"marketCap":1213990761},{"date":"2026-04-24","current":-12.508099,"twenty":-10.281908,"median":-6.792174,"eighty":0.095163,"marketCap":1751821827},{"date":"2026-05-01","current":-13.476187,"twenty":-10.362548,"median":-6.792174,"eighty":0.095163,"marketCap":1887407424},{"date":"2026-05-08","current":-12.987035,"twenty":-10.481137,"median":-6.792174,"eighty":0.095163,"marketCap":1818899252},{"date":"2026-05-15","current":-13.09064,"twenty":-10.541397,"median":-6.792174,"eighty":0.095163,"marketCap":1704204965},{"date":"2026-05-22","current":-12.460675,"twenty":-10.629123,"median":-6.792174,"eighty":0.095163,"marketCap":1622193036},{"date":"2026-05-29","current":-11.718016,"twenty":-10.669392,"median":-6.788501,"eighty":0.095189,"marketCap":1525509920},{"date":"2026-06-05","current":-10.28341,"twenty":-10.673287,"median":-6.792174,"eighty":0.095163,"marketCap":1338745722},{"date":"2026-06-12","current":-10.541481,"twenty":-10.587946,"median":-6.792174,"eighty":0.095163,"marketCap":1372342738},{"date":"2026-06-18","current":-10.61586,"twenty":-10.547355,"median":-6.792174,"eighty":0.095163,"marketCap":1382025721},{"date":"2026-06-26","current":-10.740951,"twenty":-10.52306,"median":-6.788501,"eighty":0.095189,"marketCap":1398310737},{"date":"2026-07-02","current":-10.699254,"twenty":-10.52306,"median":-6.788501,"eighty":0.095189,"marketCap":1392882398},{"date":"2026-07-10","current":-11.703366,"twenty":-10.52306,"median":-6.788501,"eighty":0.095189,"marketCap":1523602666},{"date":"2026-07-17","current":-10.037735,"twenty":-10.494482,"median":-6.788501,"eighty":0.095189,"marketCap":1306762537},{"date":"2026-07-24","current":-9.579067,"twenty":-10.450596,"median":-6.788501,"eighty":0.095189,"marketCap":1247050810},{"date":"2026-07-31","current":-9.548639,"twenty":-10.386526,"median":-6.78817,"eighty":0.095215,"marketCap":1243089589},{"date":"2026-08-07","current":-9.668096,"twenty":-10.28924,"median":-6.78817,"eighty":0.095215,"marketCap":1258641046},{"date":"2026-08-14","current":-10.967164,"twenty":-10.28341,"median":-6.78817,"eighty":0.095215,"marketCap":1427760196},{"date":"2026-08-21","current":-10.560468,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1459255989},{"date":"2026-08-28","current":-13.199786,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1823959603},{"date":"2026-09-04","current":-13.021914,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1799381111},{"date":"2026-09-11","current":-11.867346,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1639841677},{"date":"2026-09-18","current":-11.154794,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1541380531},{"date":"2026-09-25","current":-10.693605,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1477653064},{"date":"2026-10-02","current":-10.430525,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1441300443},{"date":"2026-10-09","current":-9.879869,"twenty":-10.199014,"median":-6.78817,"eighty":0.095215,"marketCap":1365210141}],"updateTime":1791664944842},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INBX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1140714808","title":"Inhibrx Biosciences公布實驗性聯合抗癌藥中期研究數據後，股價重挫22%","url":"https://stock-news.laohu8.com/highlight/detail?id=1140714808","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140714808?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 22:18","pubTimestamp":1788877090,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences股价暴跌22%，缘于该公司披露了其试验性组合癌症药物的中期阶段研究数据。市场对此反应剧烈，股价应声大幅下挫。这家生物科技企业此番公布的数据，源于一项针对该联合疗法疗效和安全性的中段临床试验。投资者在审视这些最新出炉的结果后，显然对前景产生了疑虑，进而引发了抛售潮，拖累股价在交易时段内录得显著跌幅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665132026","title":"Inhibrx的聯合抗癌藥物在頭頸部癌症中期臨床試驗中縮小了腫瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2665132026","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665132026?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869854,"startTime":"0","endTime":"0","summary":"数据显示，该联合用药使48.3%的患者肿瘤缩小或消失，而单独使用Keytruda的患者这一比例为26.5%。截至数据截止日期，接受联合用药的患者中位无进展生存期为9.6个月，而仅接受Keytruda治疗的患者为4.9个月。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S4500Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144527689","title":"Inhibrx Biosciences：INBRX-106圍手術期非小細胞肺癌Ⅰ/Ⅱ期臨床試驗進行中，初步結果預計2027年年中公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1144527689","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144527689?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 19:33","pubTimestamp":1788867232,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences正积极推进一项针对INBRX-106的Ⅰ/Ⅱ期临床研究，该试验聚焦于非小细胞肺癌（NSCLC）的围手术期治疗场景，初步数据有望于2027年年中揭晓。\n这家生物制药企业目前正全力投入INBRX-106的早期临床开发，探索其在非小细胞肺癌患者围手术期阶段的应用潜力。按照当前的时间表规划，研究团队期望能在2027年中期获取并公布首批关键性结果。\n颇具看点的是，这项研究不仅标志着INBRX-106临床适应症版图的进一步拓展，也折射出公司在肿瘤免疫治疗细分赛道的战略布局。围手术期策略的引入，意在更早期地介入肿瘤治疗流程，或将为患者带来全新的治疗契机。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187240423","title":"Inhibrx Biosciences：擬探索Inbrx-106與治療性癌症疫苗聯合應用的潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=1187240423","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187240423?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 19:32","pubTimestamp":1788867157,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences公司今日宣布，其战略布局将延伸至一个新的维度——探索其核心候选药物Inbrx-106与治疗性癌症疫苗的联合使用潜力。此举标志着该公司在肿瘤免疫治疗领域的创新步伐正进一步加快，意图通过多机制协同，开辟更广泛的抗肿瘤治疗路径。Inbrx-106作为该公司研发管线中的关键资产，其与癌症疫苗的潜在组合，不仅有望提升治疗响应率，更可能为当前应答不佳的患者群体带来新的曙光。公司方面对此寄予厚望，认为该联合策略或将在未来的临床开发中占据举足轻重的地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179108181","title":"Inhibrx Biosciences旗下INBRX-106在II期頭頸鱗癌研究中：緩解率近乎翻倍，無進展生存期中位數達9.6個月","url":"https://stock-news.laohu8.com/highlight/detail?id=1179108181","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179108181?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 19:31","pubTimestamp":1788867080,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences（INBX）公布了其候选药物INBRX-106在II期头颈鳞状细胞癌（HNSCC）临床研究中的中期数据。结果显示，该药物将缓解率提升近一倍，且无进展生存期（PFS）中位数达到了9.6个月，展现出令人鼓舞的抗肿瘤活性。这些数据预计将为后续的临床试验设计和潜在监管沟通提供关键支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135938113","title":"H.c. Wainwright首次覆蓋Inhibrx Biosciences，給予買入評級及245美元目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1135938113","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135938113?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:09","pubTimestamp":1787566149,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences（INBX）近日获得H.c. Wainwright的正式关注。该机构首次覆盖这家生物科技公司，便果断给出“买入”评级，同时将目标股价设定在245美元。这一举动，无疑为市场注入了一剂强心针。245美元的目标价，相较于当前股价，意味着相当可观的潜在上行空间。此举也反映出华尔街对Inhibrx在研管线及技术平台所蕴含价值的初步认可。H.c. Wainwright此次的积极表态，标志着Inhibrx开始进入更多投资者的视野，其后续的研发进展和商业化潜力将成为市场关注的焦点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659612865","title":"Inhibrx因季度虧損幅度超出預期而股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2659612865","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659612865?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 23:47","pubTimestamp":1786722449,"startTime":"0","endTime":"0","summary":"BUZZ-Inhibrx因季度亏损幅度超出预期而股价下跌8月14日-** 药物开发商 Inhibrx Biosciences（INBX.O）股价下跌 8.2%，报 89.09 美元** 据伦敦证券交易所集团（LSEG）数据显示，该公司报告第二季度净亏损3,670万美元，而分析师平均预期为亏损2,960万美元** INBX本季度的一般及行政费用从去年同期的640万美元升至830万美元** 公司表示，","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL4T44B11E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134591223","title":"Inhibrx Biosciences二次修訂協議帶來總計3.25億美元資金，含1億美元已到位與2.25億美元可用額度","url":"https://stock-news.laohu8.com/highlight/detail?id=1134591223","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134591223?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 21:02","pubTimestamp":1784206950,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences公司通过其第二次修订协议，成功锁定了高达3.25亿美元的资金支持。该资金安排结构清晰，其中1亿美元已确认获得融资，另有2.25亿美元作为可用额度待后续启用。这一举措显著增强了公司的财务灵活性与研发推进能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188081691","title":"Inhibrx宣佈與牛津金融修訂貸款協議，總授信額度增至5億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188081691","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188081691?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 21:01","pubTimestamp":1784206900,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences（INBX）已宣布与牛津金融（Oxford Finance）达成一项修订后的贷款协议。根据新协议，公司获得的总授信额度已扩大至5亿美元。此次修订旨在为公司提供更充足的财务灵活性，以支持其研发管线及运营需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174269329","title":"Inhibrx宣佈美國FDA受理Ozekibart用於治療常規軟骨肉瘤患者的生物製品許可申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1174269329","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174269329?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 21:16","pubTimestamp":1781529384,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences（INBX）宣布，其用于治疗常规软骨肉瘤患者的在研药物Ozekibart的生物制品许可申请（BLA）已获得美国食品药品监督管理局（FDA）的受理。FDA的受理标志着该药物审评流程的正式启动，是向潜在获批迈出的关键一步。常规软骨肉瘤是一种罕见的骨癌，目前治疗选择有限，此次BLA的受理为患者带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169839556","title":"Inhibrx Biosciences公司：Inbrx-106聯合帕博利珠單抗觀察到三例完全影像學緩解","url":"https://stock-news.laohu8.com/highlight/detail?id=1169839556","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169839556?lang=zh_tw&edition=fundamental","pubTime":"2026-05-11 20:06","pubTimestamp":1778501162,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences公司宣布，其候选药物Inbrx-106与帕博利珠单抗（Pembrolizumab）联合治疗的临床研究中，已观察到三例患者达到完全影像学缓解。\n这一积极数据展现了该联合疗法在特定患者群体中的显著抗肿瘤活性。完全影像学缓解通常意味着通过影像学检查（如CT或MRI）已无法检测到肿瘤病灶，是评估癌症治疗效果的一个重要指标。\n该结果进一步支持了Inbrx-106的开发潜力，为后续临床研究提供了有力依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181018288","title":"Inhibrx Biosciences公司：Inbrx-106聯合帕博利珠單抗確認客觀緩解率達44.0%，顯著優於單藥21.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181018288","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181018288?lang=zh_tw&edition=fundamental","pubTime":"2026-05-11 20:05","pubTimestamp":1778501143,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences公司公布了其候选药物Inbrx-106与帕博利珠单抗联合疗法的积极数据。结果显示，该联合方案取得了44.0%的确认客观缓解率，而单独使用帕博利珠单抗的对照组，其确认客观缓解率仅为21.4%。这一数据对比凸显了联合疗法在疗效上的显著优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160098811","title":"Inhibrx Biosciences公司：Inbrx-106聯合帕博利珠單抗或使系統性T細胞擴增提升高達15倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1160098811","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160098811?lang=zh_tw&edition=fundamental","pubTime":"2026-05-11 20:02","pubTimestamp":1778500935,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences公司公布的最新研究数据显示，其候选药物Inbrx-106与帕博利珠单抗联合使用时，可能引发系统性T细胞扩增高达15倍的显著提升。这一发现预示着该联合疗法在激活人体免疫系统对抗肿瘤方面具有巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144007889","title":"Inhibrx公布INBRX-106一線治療HNSCC的2期中期數據；初步結果顯示其較PD-1單藥療法具有潛在共刺激優勢","url":"https://stock-news.laohu8.com/highlight/detail?id=1144007889","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144007889?lang=zh_tw&edition=fundamental","pubTime":"2026-05-11 20:01","pubTimestamp":1778500907,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences  公布了其候选药物INBRX-106在一线治疗头颈部鳞状细胞癌患者中的2期临床试验中期数据。初步分析表明，INBRX-106可能展现出超越现有PD-1单药疗法的共刺激活性优势，为这一治疗领域带来了新的希望。头颈部鳞状细胞癌的治疗长期面临挑战，尽管免疫检查点抑制剂如PD-1单抗已取得进展，但疗效提升空间依然显著。公司表示，这些数据支持继续推进INBRX-106的临床开发计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123068912","title":"Inhibrx 將舉辦網絡直播 提供一線HNSCC中Inbrx-106六邊形研究臨床進展更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1123068912","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123068912?lang=zh_tw&edition=fundamental","pubTime":"2026-05-09 04:01","pubTimestamp":1778270476,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences (INBX) 计划通过一场网络直播会议，对外公布其候选药物 Inbrx-106 在一线治疗头颈部鳞状细胞癌 (HNSCC) 的“六边形”研究中的最新临床数据。此次更新旨在向投资者和医学界提供该试验项目进展的关键信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629043251","title":"BUZZ-Inhibrx股價上漲，其與默克Keytruda相關的實驗藥引製藥商關注","url":"https://stock-news.laohu8.com/highlight/detail?id=2629043251","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629043251?lang=zh_tw&edition=fundamental","pubTime":"2026-04-22 19:37","pubTimestamp":1776857836,"startTime":"0","endTime":"0","summary":"4月22日 - ** 生物技术公司Inhibrx Biosciences的INBX.O股价盘前上涨9%至91.49美元** 消息人士称，包括默克MRK.N、Merck KGaA和Ono Pharma在内的制药商正在关注  其实验性癌症药物INBRX-106** INBRX-106正在与Keytruda一起进行测试，旨在帮助免疫系统更好地攻击肿瘤。** 消息人士补充说，根据早期试验数据，INBRX-106可将应答率提高到约45%，而单独使用Keytruda的应答率约为30%。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL4T41517O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","BK4550","LU1989772923.USD","SG9999001176.SGD","LU1291159041.SGD","LU1162221912.USD","LU1941712264.USD","LU1066051811.HKD","LU2324357040.USD","LU2357627491.SGD","LU1093756325.SGD","LU0265550359.USD","LU2361044865.SGD","BK4588","LU0985320562.USD","BK4516","LU2360032135.SGD","IE0002141913.USD","SG9999014567.USD","LU0965509101.SGD","LU1069347547.HKD","IE0009355771.USD","LU2023250504.SGD","BK4585","SG9999013999.USD","LU0058720904.USD","IE00BLSP4452.SGD","BK4534","LU1057294990.SGD","BK4139","LU1585245621.USD","LU1061106388.HKD","SG9999014542.SGD","SG9999014575.USD","BK4559","LU2361045086.USD","LU0234572021.USD","LU1116320901.HKD","LU0861579265.USD","LU0106261372.USD","LU0070302665.USD","LU0203347892.USD","IE00BSNM7G36.USD","LU0208291251.USD","SG9999014559.SGD","IE00BFTCPJ56.SGD","LU0266013472.USD","BK4533","LU1035773651.USD","LU1093756168.USD","LU0320765646.SGD","LU0238689110.USD","LU1934455194.USD","LU1201861249.SGD","LU1430594728.SGD","SG9999001440.SGD","LU2468319806.SGD","LU0320765489.SGD","IE000M9KFDE8.USD","LU0289739699.SGD","LU0211331839.USD","LU1974910355.USD","LU0859254822.USD","LU0965508806.USD","LU1917777945.USD","LU0265550946.USD","LU1934455277.USD","SG9999001176.USD","LU2125154935.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0648001328.SGD","SG9999015341.SGD","LU0432979614.USD","LU0942090050.USD","INBX","IE00B2B36J28.USD","LU0130102774.USD","LU2125154778.USD","LU2023250843.SGD","IE00B1BXHZ80.USD","LU0980610538.SGD","LU2112291526.USD","LU0098860793.USD","LU1037948897.HKD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1941712348.USD","LU0122379950.USD","IE00BBT3K403.USD","SG9999002232.USD","LU2106854487.HKD","LU2089984988.USD","LU1934455863.HKD","LU1989771016.USD","LU2461242641.AUD","SG9999015358.SGD","LU0006306889.USD","LU0868494708.USD","SG9999002224.SGD","LU1066053197.SGD","LU1989772840.SGD","LU1037948541.HKD","LU0965509283.SGD","IE00BLSP4239.USD","LU0868494617.USD","LU1929549753.HKD","BK4007","IE00BN8TJ469.HKD","LU1066051225.USD","LU0130517989.USD","LU1023059063.AUD","LU0965509010.AUD","LU1983299246.USD","LU0203345920.USD","LU1699723380.USD","LU0477156953.USD","LU2361044949.HKD","LU1066051498.USD","LU1116320737.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111467807","title":"Inhibrx Biosciences盤前大漲6.2% 路透報道其實驗性抗癌藥物引默克及同業競逐","url":"https://stock-news.laohu8.com/highlight/detail?id=1111467807","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111467807?lang=zh_tw&edition=fundamental","pubTime":"2026-04-22 19:08","pubTimestamp":1776856092,"startTime":"0","endTime":"0","summary":"生物科技公司Inhibrx Biosciences股价在盘前交易中强势攀升6.2%，此前路透社报道称，该公司旗下的一款实验性抗癌药物已吸引制药巨头默克及其竞争对手的收购兴趣。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010272","title":"獨家-消息人士稱，默克與競爭對手有意就與 Keytruda 相關的 Inhibrx 實驗性抗癌藥物達成交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010272","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629010272?lang=zh_tw&edition=fundamental","pubTime":"2026-04-22 19:01","pubTimestamp":1776855664,"startTime":"0","endTime":"0","summary":"人们的兴趣主要集中在 INBRX-106 上，该药正在接受  单独试验以及与默克公司的 Keytruda 联合试验。Keytruda获准用于治疗多种癌症，2025年的销售额几乎占默克公司全球销售额的一半。Inhibrx 拒绝发表评论。Ozekibart旨在促进癌细胞死亡。周二，Inhibrx 的股价报收于 84.08 美元。在默克公司开始面临价格较低的Keytruda生物仿制药的竞争之前，这种药物不太可能上市。其中一位人士说，Inhibrx公司正在考虑一种类似于2024年与赛诺菲SASY.PA交易的分拆结构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL4T41512H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","LU2023250843.SGD","ELIS","LU0426412945.USD","LU0426417589.USD","LU0061475181.USD","IE00BKPKM429.USD","LU0390134368.USD","LU1496350171.SGD","IE00BDGV0183.EUR","SG9999014880.SGD","IE00B7KXQ091.USD","LU0114720955.EUR","LU2211815571.USD","LU1043141396.HKD","LU0211327993.USD","LU2491049909.HKD","LU1051770623.HKD","IE0000B7K699.USD","LU1720051017.SGD","IE00BJJMRY28.SGD","LU0499090636.EUR","SG9999003800.SGD","LU0256863902.USD","LU0345769128.USD","LU1868836757.USD","IE00BJJMRX11.SGD","INBX","LU0787776722.HKD","LU1894683264.USD","LU0265550946.USD","LU0323591593.USD","LU0784383803.USD","LU0557290698.USD","LLYX","LU0128525689.USD","LLYZ","LU1046234339.USD","LU2237443465.HKD","LU2114397693.USD","LU1019634622.SGD","IE00BN8TJ469.HKD","LU2471134523.USD","IE0004445015.USD","LU0823434740.USD","LU0823434583.USD","LU0320765059.SGD","LU2237438978.USD","LU2125154935.USD","LU2361045086.USD","LU0306806265.USD","SG9999015358.SGD","LU0827474353.SGD","LU0053666078.USD","LU0960981461.USD","LU2430703095.HKD","LU0158827781.USD","LU0345777659.USD","BK4592","IE00BZ1G4Q59.USD","SG9999017495.SGD","IE00B19Z3581.USD","LU1201861249.SGD","SG9999015978.USD","LU2430703178.SGD","LU2505996509.AUD","SG9999018857.SGD","LU1868836914.USD","LU0889566641.SGD","LU2539964713.USD","LU1988902786.USD","LU0708994859.HKD","LU0471298777.SGD","LU1145028129.USD","LU0887340254.USD","LU0208291251.USD","LU1244550577.SGD","LU2168563687.JPY","LU0128525929.USD","LU0203202063.USD","LU0170899867.USD","LU1069344957.HKD","LU1221951046.USD","LU0047473722.EUR","LU0094547139.USD","LU2237443549.SGD","LU0882574139.USD","SG9999015945.SGD","LU0070217475.USD","LU0070302665.USD","IE00BJJMRZ35.SGD","LU0466842654.USD","LU2168564495.EUR","IE00BFSS7M15.SGD","IE00BLSP4452.SGD","LU0079474960.USD","IE00BFSS8Q28.SGD","LU0225284248.USD","IE00BWXC8680.SGD","LU1974910355.USD","LU0171293334.USD","IE00B4R5TH58.HKD","IE00BKPKM643.USD","LU0708995401.HKD","LU2168564222.USD","LU0133085943.USD","LU1267930573.SGD","IE00BJT1NW94.SGD","LU0052756011.USD","LU1551013425.SGD","LU2462157665.USD","IE0002270589.USD","BK4504","LU2361044949.HKD","LU0320765489.SGD","LLII","LU1941712264.USD","SG9999015986.USD","LU0385154629.USD","LU1699723380.USD","LU0640476718.USD","LU2089284900.SGD","SG9999018865.SGD","BK4533","LU0203345920.USD","LU1003076772.USD","LU1804176565.USD","LU0689626769.HKD","LU0306807586.USD","LU1674673428.USD","LU0861579265.USD","LU0109391861.USD","LU2129689514.USD","BK4550","BK4599","LU1064131342.USD","LU2433249047.HKD","LU2491050154.USD","LU2129689431.USD","LU1059921491.USD","LU1366192091.USD","LU0969580561.USD","LU0784385840.USD","LU1712237335.SGD","LU2125909247.SGD","LU1935042991.SGD","LU1506573853.SGD","LU0345770308.USD","LU1093756325.SGD","LU0256863811.USD","LU0058720904.USD","LU2237443382.USD","SG9999001176.USD","SG9999015341.SGD","SGXZ99366536.SGD","LU0964807845.USD","LU0203347892.USD","MRK","LU0109394709.USD","LU2125154778.USD","LU0859254822.USD","LU2023251221.USD","LU1035773651.USD","LU0757432116.USD","LU1301847155.USD","LU2028103732.USD","SG9999001176.SGD","LU0158827948.USD","LU1074936037.SGD","LU0130517989.USD","LU0477156953.USD","LU0792757196.USD","LU2468319806.SGD","LU0047473722.SGD","LU2063271972.USD","LU0957799991.USD","LU1153584641.USD","IE00B1XK9C88.USD","LU1732800096.USD","SG9999014906.USD","LU2461242641.AUD","BK4568","LU0316494557.USD","IE00BVYPNW00.USD","LU0456855351.SGD","LU1066051225.USD","LU1481599808.USD","IE00BFXG1179.USD","LU1880407215.USD","LU1989771016.USD","IE00B775H168.HKD","LU0321505868.SGD","LU0784385170.HKD","SG9999014914.USD","LU1430594728.SGD","LU1066051811.HKD","LU1718418525.SGD","LU2293690082.USD","LU0011850046.USD","LU1674673691.USD","LU1941712348.USD","LU0345769631.USD","LU1481600234.SGD","LU2417539215.USD","LU2750360641.GBP","IE00BKVL7J92.USD","LU0965508806.USD","BK4581","LU2087625088.SGD","IE00BJLML261.HKD","LU1084165304.USD","LU2265009873.SGD","BK4007","LU2324357040.USD","IE00BKDWB100.SGD","LU0006306889.USD","LU2471134879.HKD","LU0661504455.SGD","LU1267930227.SGD","LU0920783379.SGD","LU2357305700.SGD","IE00BGHQF631.EUR","LU2505996681.GBP","LU2487616109.SGD","LU0266013472.USD","LU2089984988.USD","LU2213496289.HKD","BK4139","LU2237443978.SGD","BK4534","IE00BFTCPJ56.SGD","LU1720051108.HKD","IE000M9KFDE8.USD","SGXZ51526630.SGD","LU0889565916.HKD","IE00B19Z3B42.SGD","LU2756315318.SGD","LU0320765992.SGD","BK5011","IE00B3T34201.USD","LU1814569148.SGD","LU0575583348.USD","LU0122379950.USD","LU0310799852.SGD","LU0211328371.USD","LU1989772923.USD","LU2125909593.SGD","IE000F7OJYX1.SGD","LU0265550359.USD","LU0823399737.USD","LU1221951129.SGD","LU0321505439.SGD","LU2355687059.USD","SG9999014575.USD","LU0353189763.USD","LU0648001328.SGD","LU0882574055.USD","LU1069347547.HKD","LU1064927863.SGD","LU0098860793.USD","LU0820561818.USD","LU2471134952.CNY","LU1983299246.USD","LU0965509283.SGD","LU0672654240.SGD","LU1267930730.SGD","LU2471134796.USD","LU1032466523.USD","LU1170363599.USD","IE00BVYPNV92.GBP","SGXZ31699556.SGD","LU1732799900.SGD","LU2168564065.EUR","LU1116320737.USD","SG9999002224.SGD","LU0345770993.USD","LU0353189680.USD","IE000MB6IJN5.SGD","LU0097036916.USD","SG9999002232.USD","LU2430703251.USD","LU0198837287.USD","BK4585","LU1487256676.USD","LU0432979614.USD","IE00B3PB1722.GBP","LU0689472784.USD","IE00BBT3K403.USD","LU0211326755.USD","LU2279689827.SGD","BK4532","LU2111349929.HKD","LU0238689110.USD","LU1883839398.USD","LU0964806797.USD","LU1153585028.USD","LU2746668461.USD","LU1162221912.USD","LU1323610961.USD","SGXZ81514606.USD","LU1019632923.USD","LU0997586432.USD","LU1894683348.USD","LU0345777147.USD","LU0820561909.HKD","BK4559","LU0868494708.USD","LU0868494617.USD","LU1061106388.HKD","IE00BLSP4239.USD","LU0980610538.SGD","ELIL","LU0320765646.SGD","LU0965509101.SGD","LU1629891620.HKD","LU0943347566.SGD","IE00BN29S564.USD","LU1778281490.HKD","LU2271345857.HKD","LU2361044865.SGD","LU1196500208.SGD","LU0526926950.USD","LU2023250504.SGD","LU0997586515.USD","LU0130102774.USD","IE0002141913.USD","LU0795875086.SGD","IE0009355771.USD","LU2023250330.USD","LU1037948541.HKD","GB00BDT5M118.USD","LU0823416689.USD","LU1057294990.SGD","SG9999014542.SGD","LU2592432038.USD","LU1037948897.HKD","LU1015430645.USD","LU1868837136.USD","LU0210528500.USD","LU1093756168.USD","LU1116320901.HKD","LU1003077747.HKD","LU1917777945.USD","LU2347655156.SGD","LU1291159041.SGD","LU0211331839.USD","LU1934455277.USD","LU2360106947.USD","LU0965509010.AUD","LU2896262040.SGD","LU0963555726.SGD","IE00B42XCP33.USD","LU1267930813.SGD","LU1104425308.USD","LU0784384876.USD","LU0225283273.USD","LU1232071149.USD","LU1929549753.HKD","LU1267930490.SGD","IE000SO60NU8.SGD","LU2264538146.SGD","LU1868837300.USD","LU0920840948.USD","LU0234570918.USD","IE00BK4W5L77.USD","LU0354030438.USD","LU1623119135.USD","LU0795875169.SGD","IE00BK4W5M84.HKD","LU2456880835.USD","LU0683600562.USD","LU0234572021.USD","LU1868836591.USD","SG9999011175.SGD","LU1244550494.USD","LU2106854487.HKD","IE000BZT7R73.USD","LU2112291526.USD","LU2089283258.USD","LU1244550221.USD","LU2491050071.SGD","LU0949170426.SGD","IE00B1BXHZ80.USD","BK4588","LU0949170772.SGD","LU1571399168.USD","LU2129689605.HKD","LU1880407132.USD","LU0738911758.USD","SG9999001440.SGD","LU2756315664.SGD","LU1914381329.SGD","LU1934455194.USD","LU0210536198.USD","LU2552382058.USD","LU1261432733.SGD","LU0310800965.SGD","LU1066051498.USD","LU1121112475.USD","LU2091194634.USD","LU0077335932.USD","LU0994945656.USD","LU2602419157.SGD","LU0096364046.USD","IE0034235188.USD","LU0289739699.SGD","LU0942090050.USD","IE0034235303.USD","LU1023059063.AUD","BK4516","LU0985481810.HKD","LU2168564149.EUR","03165","LU0225771236.USD","LU0985320562.USD","LU1043141123.HKD","LU2552382215.SGD","LU0976567544.SGD","IE00B2B36J28.USD","LU0496365809.HKD","LU0889565080.SGD","SG9999014898.SGD","LU0417517546.SGD","LU0029864427.USD","LU2237443622.USD","LU1585245621.USD","LU2108987350.USD","LU0857590862.USD","IE00BSNM7G36.USD","SG9999015952.SGD","SG9999014559.SGD","LU1066053197.SGD","LU0545039389.USD","SGXZ57979304.SGD","LU2552382132.HKD","IE000WAW04H5.SGD","LU1196032939.SGD","IE00B4JS1V06.HKD","LU1496350502.SGD","LU0471298694.HKD","LU1127390331.HKD","LU1280957306.USD","SG9999014567.USD","LU1035775433.USD","IE0005OL40V9.USD","LU0553294199.USD","LU0912757837.SGD","LU1923622614.USD","LU0972486137.USD","LU2133065610.SGD","LU1273509221.SGD","LU2746668974.SGD","LU1078025761.USD","IE00B7SZLL34.SGD","LU1032955483.USD","LU2750360997.AUD","LU1548497426.USD","LU0786609619.USD","IE0004445239.USD","LU0354030511.USD","LU2360032135.SGD","LU0310800379.SGD","LU0124676726.USD","SG9999013999.USD","LU2293690249.USD","LU1119994496.HKD","LU0203201768.USD","LU2236285917.USD","LU0640478417.SGD","LU0820562030.AUD","LU2357627491.SGD","LU1989772840.SGD","LU1934455863.HKD","LU2237443895.HKD","LU1551013342.USD","IE0001KFT4U8.USD","LU0211326839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156179722","title":"Inhibrx將舉辦網絡直播會議 公布Ozekibart (INBRX-109)治療晚期結直腸癌臨床進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1156179722","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156179722?lang=zh_tw&edition=fundamental","pubTime":"2026-04-21 05:05","pubTimestamp":1776719114,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences（纳斯达克代码：INBX）宣布将举办专题网络直播会议，重点介绍其核心候选药物Ozekibart（研发代号：INBRX-109）在晚期结直肠癌治疗领域的最新临床数据。此次会议将面向投资者和医学界专业人士，深入解析该药物在末线治疗中的疗效与安全性表现。\n公司管理层及临床研究负责人将出席本次会议，通过详实的数据展示与案例分析，全面呈现Ozekibart在难治性结直肠癌患者群体中的治疗潜力。与会者可通过在线平台实时参与互动研讨，获取第一手临床研究进展信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}